Terug
Dagbereik
€ 46,40
€ 47,84
52-Weeksbereik
€ 30,04
€ 78,48
Volume
1.441.615
50D / 200D Gem.
€ 53,33
/
€ 55,91
Vorige Slotkoers
€ 46,24
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,7 | 0,4 |
| P/B | 2,3 | 2,9 |
| ROE % | -30,2 | 3,8 |
| Net Margin % | -16569,8 | 3,9 |
| Rev Growth 5Y % | -75,1 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 65,00
+38.7%
Low: € 33,00
High: € 82,00
Forward WPA
-€ 4,86
Omzet Sch.
49 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 18,33
-€ 4,93 – € 87,66
|
4,9 B | 3 |
| FY2029 |
€ 3,16
-€ 0,85 – € 15,11
|
1,9 B | 3 |
| FY2028 |
-€ 2,47
-€ 11,73 – € 12,57
|
530 M | 9 |
Belangrijkste Punten
Revenue declined -75,10% annually over 5 years
Debt/Equity of 0,21 — conservative balance sheet
Negative free cash flow of -345,93M
Revenue growth is decelerating — 1Y growth trails 5Y average by 14,87%
Groei
Revenue Growth (5Y)
-75,10%
Revenue (1Y)-89,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-30,18%
ROIC-18,40%
Net Margin-16569,77%
Op. Margin-16191,40%
Veiligheid
Debt / Equity
0,21
Current Ratio13,32
Interest Coverage0,00
Waardering
P/E Ratio
-7,74
P/B Ratio2,34
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -89,97% | Revenue Growth (3Y) | -90,26% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -75,10% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,51M | Net Income (TTM) | -581,60M |
| ROE | -30,18% | ROA | -25,67% |
| Gross Margin | -6537,01% | Operating Margin | -16191,40% |
| Net Margin | -16569,77% | Free Cash Flow (TTM) | -345,93M |
| ROIC | -18,40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,21 | Current Ratio | 13,32 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,74 | P/B Ratio | 2,34 |
| P/S Ratio | 1281,99 | PEG Ratio | -0,17 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,50B | Enterprise Value | 4,54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,51M | 35,00M | 370,00M | 436.000,0 | 913,08M |
| Net Income | -581,60M | -366,25M | -153,61M | -650,18M | 377,66M |
| EPS (Diluted) | -6,47 | -4,34 | -1,94 | -8,36 | 4,70 |
| Gross Profit | -229,45M | -75,25M | 239,75M | -109,81M | 811,90M |
| Operating Income | -568,32M | -466,57M | -222,54M | -673,16M | 373,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,27B | 2,24B | 2,23B | 2,24B | 2,75B |
| Total Liabilities | 343,43M | 309,95M | 346,77M | 367,58M | 352,42M |
| Shareholders' Equity | 1,92B | 1,93B | 1,88B | 1,88B | 2,40B |
| Total Debt | 394,91M | 223,69M | 238,63M | 244,02M | 225,03M |
| Cash & Equivalents | 355,19M | 298,26M | 389,48M | 211,89M | 923,03M |
| Current Assets | 1,99B | 1,94B | 1,91B | 1,85B | 2,42B |
| Current Liabilities | 149,12M | 87,78M | 108,79M | 121,11M | 119,88M |